Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 6/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24537215 | 0.95 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537218 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537221 | 0.93 | KDM4E (0.36) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537239 | 0.92 | KDM4E (0.39) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537574 | 0.91 | L3MBTL1 (0.42) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537216 | 0.90 | L3MBTL1 (0.44) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537226 | 0.90 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537505 | 0.90 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24536877 | 0.87 | BCHE (0.36) | KDM4EATML3MBTL1HDAC4BCHE | |
| SCHEMBL24537563 | 0.86 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220199912-A1 | LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220199912-A1 | LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME | LAGE3, ASIC1, ALG3 | KDM4E 1437/4885ATM 4791/4885L3MBTL1 135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.